Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

Enliven Therapeutics (ELVN) SEC Filings & 10K Form

Enliven Therapeutics logo
$19.77 -0.22 (-1.10%)
Closing price 04:00 PM Eastern
Extended Trading
$19.78 +0.02 (+0.08%)
As of 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Enliven Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
08/11/2025
5:51 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Patel Anish (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2025
4:57 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Hohl Benjamin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2025
5:52 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Lyssikatos Joseph P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2025
6:21 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Kintz Samuel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2025
6:54 PM		BlackRock, Inc. (Filed by)
Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Form SCHEDULE 13G/A
07/17/2025
3:13 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Kintz Samuel (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/14/2025
4:07 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Hohl Benjamin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2025
6:29 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Patel Anish (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2025
3:15 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Patel Anish (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/01/2025
3:42 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Hohl Benjamin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2025
3:05 PM		Enliven Therapeutics, Inc. (Filer)
Enliven Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/24/2025
4:36 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Lyssikatos Joseph P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
5:22 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Kintz Samuel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2025
4:30 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SCHEDULE 13D/A
06/17/2025
3:24 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Hohl Benjamin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
5:44 AM		Enliven Therapeutics, Inc. (Filer)
Enliven Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2025
8:39 PM		Enliven Therapeutics, Inc. (Filer)
Enliven Therapeutics (Filer)
Form 424B5
06/13/2025
5:17 AM		Enliven Therapeutics, Inc. (Filer)
Enliven Therapeutics (Filer)
Form 424B5
06/13/2025
5:26 AM		Enliven Therapeutics, Inc. (Filer)
Enliven Therapeutics (Filer)
Form S-3MEF
06/13/2025
5:05 AM		Enliven Therapeutics, Inc. (Filer)
Enliven Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2025
5:25 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Patel Anish (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025
3:21 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Patel Anish (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/05/2025
3:53 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Kintz Samuel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
3:55 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Lyssikatos Joseph P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
4:34 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Kintz Samuel (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/03/2025
4:14 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Lyssikatos Joseph P (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/29/2025
4:38 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Hohl Benjamin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2025
5:29 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Kintz Samuel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2025
5:31 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Lyssikatos Joseph P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
3:21 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Lyssikatos Joseph P (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/19/2025
3:22 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Kintz Samuel (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/09/2025
5:48 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Patel Anish (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
5:42 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Kintz Samuel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
5:43 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Lyssikatos Joseph P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2025
5:59 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Hohl Benjamin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2025
3:08 PM		Enliven Therapeutics, Inc. (Filer)
Enliven Therapeutics (Filer)
Form DEFA14A
04/28/2025
3:12 PM		Enliven Therapeutics, Inc. (Filer)
Enliven Therapeutics (Filer)
Form ARS
04/21/2025
4:55 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Kintz Samuel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2025
3:25 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Patel Anish (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2025
3:09 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Patel Anish (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/31/2025
6:37 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Hohl Benjamin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
New law could create $3.7 trillion tsunami. (Ad)

During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’s Project MAFA,” and it could soon return America to a “new” gold standard. The Trump administration, Wall Street, and Silicon Valley are all pushing it forward. The President himself calls the plan “incredible.” Already, it’s helping small plays jump as high as 300%, 318%, 520%, and even 600%.

You can watch it right here.
03/27/2025
3:01 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Hohl Benjamin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/26/2025
6:37 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Hohl Benjamin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2025
4:49 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Lyssikatos Joseph P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:42 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Kintz Samuel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
3:18 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Lyssikatos Joseph P (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/18/2025
4:33 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Kintz Samuel (Reporting)
Form 144/A
03/18/2025
4:22 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Kintz Samuel (Reporting)
Form 144/A
03/18/2025
3:06 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Kintz Samuel (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/17/2025
3:14 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Kintz Samuel (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/13/2025
4:05 PM		Enliven Therapeutics, Inc. (Filer)
Enliven Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/07/2025
3:18 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Patel Anish (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2025
5:02 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Hohl Benjamin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
7:07 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Hohl Benjamin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
3:10 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Hohl Benjamin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2025
4:02 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Patel Anish (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2025
2:45 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Fairmount Funds Management LLC (Filed by)
Form SCHEDULE 13G/A
02/14/2025
8:17 AM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Polar Capital Holdings Plc (Filed by)
Form SCHEDULE 13G/A
02/10/2025
4:36 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Gupta Rishi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
4:38 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Heyman Richard A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
4:39 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Kunkel Lori Anne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
4:40 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Phillips Andrew John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
4:25 PM		Collins Helen Louise (Reporting)
Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
4:27 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Hohl Benjamin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
4:28 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Kintz Samuel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
4:29 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Lyssikatos Joseph P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
4:32 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Patel Anish (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
4:33 PM		Ballal Rahul D. (Reporting)
Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
4:34 PM		Bauer Jake (Reporting)
Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
4:35 PM		Derynck Mika K (Reporting)
Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
6:06 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Hohl Benjamin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
6:21 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Hohl Benjamin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
3:37 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Hohl Benjamin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/14/2025
3:06 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Patel Anish (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/14/2025
3:01 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Patel Anish (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/10/2025
4:31 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Patel Anish (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:43 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Hohl Benjamin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:21 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Patel Anish (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/31/2024
4:18 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Hohl Benjamin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
3:33 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Hohl Benjamin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/16/2024
3:15 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Patel Anish (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/02/2024
4:18 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Hohl Benjamin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2024
3:28 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Patel Anish (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
4:46 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G/A
11/14/2024
4:48 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SC 13G/A
11/14/2024
3:24 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Form SC 13G/A
11/13/2024
4:55 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Polar Capital Holdings Plc (Filed by)
Form SC 13G
11/13/2024
3:15 PM		Enliven Therapeutics, Inc. (Filer)
Enliven Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2024
1:17 PM		BlackRock, Inc. (Filed by)
Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Form SC 13G
10/30/2024
5:04 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Hohl Benjamin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/24/2024
1:02 PM		BlackRock, Inc. (Filed by)
Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Form SC 13G
Musk’s Project Colossus could mint millionaires (Ad)

I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.

All the details are waiting for you now — but you need to act before the September 1st funding windo
10/22/2024
3:18 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Heyman Richard A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2024
3:19 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Hohl Benjamin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2024
3:21 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Kintz Samuel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2024
3:22 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Lyssikatos Joseph P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2024
3:23 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Patel Anish (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2024
3:17 PM		Collins Helen Louise (Reporting)
Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
5:42 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Patel Anish (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/18/2024
4:27 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Heyman Richard A. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/18/2024
4:42 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Lyssikatos Joseph P (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:ELVN) was last updated on 8/14/2025 by MarketBeat.com Staff
From Our Partners
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...
Priority Gold | Sponsored
When the levee breaks
The U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...
Porter & Company | Sponsored
Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...
Brownstone Research | Sponsored
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsored
But this $20 American company could control the secret
The "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...
The Oxford Club | Sponsored
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsored
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Paradigm Press | Sponsored
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsored